For Monkeypox Testing, Use Lesion Swab Specimens to Avoid False Results

Home
For Monkeypox Testing, Use Lesion Swab Specimens to Avoid False Results

July 25, 2022 Center for Disease Control

Tweet

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.

On July 15, 2022 the CDC alerted laboratories that the FDA has issued a safety communication advising laboratories to use swab specimens taken directly from a lesion (rash or growth) when testing for monkeypox virus. Testing other types of specimens may lead to false results.

FDA Updates COVID-19 Test Policy and FAQs October 10, 2022
CDC Issues Select Agent Gram for Monkeypox Virus October 10, 2022
HHS Declaration of Public Health Emergency for Monkeypox Diagnostics and New FDA Guidance October 10, 2022
Variant Influenza Virus Infections September 06, 2022
Best Practices for Suspected Monkeypox Lesion Specimen Collection September 05, 2022

FDA Updates COVID-19 Test Policy and FAQs October 10, 2022
CDC Issues Select Agent Gram for Monkeypox Virus October 10, 2022
HHS Declaration of Public Health Emergency for Monkeypox Diagnostics and New FDA Guidance October 10, 2022
Variant Influenza Virus Infections September 06, 2022
Best Practices for Suspected Monkeypox Lesion Specimen Collection September 05, 2022

Posts by Tag

CDC LOCS (4)

Search Blog:

Careers | Press Room

9881 Broken Land Pkwy Suite 200 | Columbia, MD 21046-3016
Phone (800) 981-9883 | Fax (410) 381-8611 | Email info@cola.org